Zarina Shulgau

497 total citations
57 papers, 355 citations indexed

About

Zarina Shulgau is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Zarina Shulgau has authored 57 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Organic Chemistry, 7 papers in Molecular Biology and 7 papers in Pharmacology. Recurrent topics in Zarina Shulgau's work include Synthesis and biological activity (20 papers), Synthesis and Biological Evaluation (10 papers) and Synthesis and Characterization of Heterocyclic Compounds (9 papers). Zarina Shulgau is often cited by papers focused on Synthesis and biological activity (20 papers), Synthesis and Biological Evaluation (10 papers) and Synthesis and Characterization of Heterocyclic Compounds (9 papers). Zarina Shulgau collaborates with scholars based in Kazakhstan, Russia and United Kingdom. Zarina Shulgau's co-authors include И. В. Кулаков, Т. М. Сейлханов, Alexander S. Fisyuk, Yu. V. Gatilov, Mohamad Aljofan, A. E. Gulyaev, Zhaxybay Zhumadilov, Амрит Пузари, Аlmagul Kushugulova and О. А. Нуркенов and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Zarina Shulgau

50 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zarina Shulgau Kazakhstan 11 208 98 22 21 20 57 355
Belal O. Al‐Najjar Jordan 11 138 0.7× 138 1.4× 35 1.6× 11 0.5× 13 0.7× 44 373
Ji-Wang Chern Taiwan 8 249 1.2× 126 1.3× 25 1.1× 9 0.4× 23 1.1× 12 409
Varsha Menon United Arab Emirates 11 75 0.4× 184 1.9× 25 1.1× 14 0.7× 25 1.3× 20 351
Charles Q. Meng Canada 10 255 1.2× 141 1.4× 67 3.0× 31 1.5× 49 2.5× 16 482
Rehab Mustafa Badi Saudi Arabia 10 122 0.6× 132 1.3× 31 1.4× 7 0.3× 10 0.5× 32 372
Dipesh S. Harmalkar South Korea 11 222 1.1× 168 1.7× 65 3.0× 7 0.3× 13 0.7× 18 473
Swamy Jagadish India 12 216 1.0× 197 2.0× 54 2.5× 8 0.4× 9 0.5× 19 493
Amit N. Pandya India 14 242 1.2× 85 0.9× 16 0.7× 11 0.5× 3 0.1× 21 467
Sakshi Balwani India 12 140 0.7× 134 1.4× 30 1.4× 4 0.2× 12 0.6× 15 413
Mohammed Khaled Bin Break Saudi Arabia 11 131 0.6× 139 1.4× 25 1.1× 4 0.2× 21 1.1× 36 409

Countries citing papers authored by Zarina Shulgau

Since Specialization
Citations

This map shows the geographic impact of Zarina Shulgau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zarina Shulgau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zarina Shulgau more than expected).

Fields of papers citing papers by Zarina Shulgau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zarina Shulgau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zarina Shulgau. The network helps show where Zarina Shulgau may publish in the future.

Co-authorship network of co-authors of Zarina Shulgau

This figure shows the co-authorship network connecting the top 25 collaborators of Zarina Shulgau. A scholar is included among the top collaborators of Zarina Shulgau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zarina Shulgau. Zarina Shulgau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shulgau, Zarina, et al.. (2025). The Role of Exosomes in Cancer Progression and Therapy. Biology. 14(1). 27–27. 5 indexed citations
2.
Shulgau, Zarina, et al.. (2025). Cell-Based Drug Delivery Systems: Innovative Drug Transporters for Targeted Therapy. International Journal of Molecular Sciences. 26(17). 8143–8143. 2 indexed citations
4.
5.
Shulgau, Zarina, et al.. (2024). Investigating the Suitability of Mare’s Milk-Derived Exosomes as Potential Drug Carriers. Biomolecules. 14(10). 1247–1247. 6 indexed citations
6.
Shulgau, Zarina, et al.. (2023). Glycyrrhiza glabra L. Extracts and Other Therapeutics against SARS-CoV-2 in Central Eurasia: Available but Overlooked. Molecules. 28(16). 6142–6142. 2 indexed citations
7.
Shulgau, Zarina, et al.. (2023). Synthesis, hemorheological and antifibrotic activity of newly synthesized 3-acetyl-2,4,6-trimethylpyridine derivatives. Arabian Journal of Chemistry. 16(7). 104821–104821.
8.
Shulgau, Zarina, et al.. (2023). Blueberry and cranberry extracts mitigate CCL4-induced liver damage, suppressing liver fibrosis, inflammation and oxidative stress. Heliyon. 9(4). e15370–e15370. 14 indexed citations
9.
Shulgau, Zarina, et al.. (2023). Potential Antifibrotic Effect of Blueberry and Grape Polyphenol Extracts in Acute and Subacute Bleomycin-Induced Lung Tissue Injury Models in Mice. International Journal of Morphology. 41(1). 51–58. 1 indexed citations
10.
Нуркенов, О. А., et al.. (2023). Synthesis, structure and biological activity of hydrazones derived from 2- and 4-hydroxybenzoic acid hydrazides. Chemical Data Collections. 48. 101089–101089. 7 indexed citations
11.
Shulgau, Zarina, et al.. (2022). Synthesis, Molecular Docking, and Hemorheological Activity of New 4-(Thien-2-yl)-3-aminopyridine-2(1H)-one Derivatives. Russian Journal of General Chemistry. 92(9). 1692–1705. 6 indexed citations
12.
Вологжанина, Анна В., et al.. (2022). Reaction Products of β-Aminopropioamidoximes Nitrobenzenesulfochlorination: Linear and Rearranged to Spiropyrazolinium Salts with Antidiabetic Activity. Molecules. 27(7). 2181–2181. 5 indexed citations
13.
Shulgau, Zarina, et al.. (2022). Cytoprotective Activity of Newly Synthesized 3-(Arylmethylamino)-6-Methyl-4-Phenylpyridin-2(1H)-Ones Derivatives. Molecules. 27(17). 5362–5362. 4 indexed citations
15.
Shulgau, Zarina, et al.. (2022). Wound healing and anti-inflammatory effects of recombinant human angiogenin. SHILAP Revista de lepidopterología. 22(3). 293–307.
16.
Вологжанина, Анна В., et al.. (2022). Crystal structure and antidiabetic activity of 2-aminospiropyrazolinium tosylates and the product of O-tosylation of β-(benzimidazol-1-yl)propioamidoxime. Acta Crystallographica Section C Structural Chemistry. 78(10). 542–551. 1 indexed citations
17.
Shulgau, Zarina, et al.. (2022). Synthesis and Antiviral Properties against SARS-CoV-2 of Epoxybenzooxocino[4,3-b]Pyridine Derivatives. Molecules. 27(12). 3701–3701. 9 indexed citations
19.
Shulgau, Zarina, et al.. (2021). Synthesis and neurotropic activity of new 3-(arylmethyl)aminopyridine-2(1H)-one. Chemical Papers. 75(9). 4729–4739. 10 indexed citations
20.
Shulgau, Zarina, et al.. (2020). THE STUDY OF PHENOLIC COMPOUNDS OF THE BERRIES OF THREE SPECIES OF PLANTS OF THE GENUS VACCINIUM, GROWING IN THE KHANTY-MANSI AUTONOMOUS AREA. chemistry of plant raw material. 107–116. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026